Literature DB >> 25231824

The feasibility of percutaneous renal cryoablation under local anaesthesia.

Eric de Kerviler1, Constance de Margerie-Mellon, Alexandre Coffin, Guillaume Legrand, Matthieu Resche-Rigon, Guillaume Ploussard, Paul Meria, Pierre Mongiat-Artus, François Desgrandchamps, Cédric de Bazelaire.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the feasibility of cryoablation of renal tumours without sedation.
MATERIALS AND METHODS: We prospectively evaluated 149 computed tomography-guided renal cryoablation procedures that were performed at our institution between 2009 and 2013. The patients received only 1 g of IV paracetamol prior to the procedure; intraprocedural, local anaesthesia was administered. We recorded the date and duration of the procedure, size and location of the tumour, number of cryoneedles used, need for dissection with saline or carbon dioxide and intraprocedural degree of pain, which was scored using an established visual analogue pain score (VAS) (0-10). Multivariate analysis was used to identify the associations between the recorded parameters and VAS.
RESULTS: An interventional radiologist and a technician could perform all procedures without the help of anaesthesiologists and with adequate analgesia. The pain level ranged from 0 to 8 (mean, 2.0). It did not correlate with the tumour size or with the number of cryoneedles. It was significantly greater when the ice ball involved renal cavities (p = .0033) and when carbon dioxide was used for dissection (p < .0001). Conversely, the team experience was positively correlated with lower pain levels (p = .0381).
CONCLUSION: This study demonstrates that the cryoablation of renal tumours is feasible by interventional radiologists alone using a combination of IV paracetamol and local anaesthesia.

Entities:  

Mesh:

Year:  2014        PMID: 25231824     DOI: 10.1007/s00270-014-0995-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  5 in total

1.  Management of superior vena cava syndrome in critically ill cancer patients.

Authors:  Sarah Morin; Adeline Grateau; Danielle Reuter; Eric de Kerviler; Constance de Margerie-Mellon; Cédric de Bazelaire; Lara Zafrani; Benoit Schlemmer; Elie Azoulay; Emmanuel Canet
Journal:  Support Care Cancer       Date:  2017-08-24       Impact factor: 3.603

2.  Safety and effectiveness of percutaneous renal cryoablation with conscious sedation.

Authors:  Sagar Rohitkumar Patel; Sean Francois; Tiagpaul Bhamber; Holt Evans; Kris Gaston; Stephen B Riggs; Chris Teigland; Peter E Clark; Ornob P Roy
Journal:  Arab J Urol       Date:  2020-03-23

3.  Kidney cancer focal cryoablation trend: does location or approach matter?

Authors:  O Rodriguez Faba; F Sanguedolce; P Grange; G Kooiman; A Bakavicius; P De la Torre; J Palou
Journal:  World J Urol       Date:  2015-10-26       Impact factor: 4.226

Review 4.  Interventional oncology at the time of COVID-19 pandemic: Problems and solutions.

Authors:  A Denys; B Guiu; P Chevallier; A Digklia; E de Kerviler; T de Baere
Journal:  Diagn Interv Imaging       Date:  2020-04-23       Impact factor: 4.026

5.  Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center.

Authors:  Stefano Cernic; Cristina Marrocchio; Riccardo Ciabattoni; Ilaria Fiorese; Fulvio Stacul; Fabiola Giudici; Michele Rizzo; Maria Assunta Cova
Journal:  Medicina (Kaunas)       Date:  2021-03-20       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.